| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $18.3M | — | +29.5% |
| Cost of Revenue | $262K | — | — |
| R&D Expense | $65.3M | — | +16.6% |
| SG&A Expense | $31.6M | — | +38.2% |
| Operating Income | -$78.8M | — | -21.8% |
| Pre-tax Income | -$73.3M | — | -28.2% |
| Income Tax | $8K | — | -96.5% |
| Net Income | -$73.3M | — | -27.7% |
| EPS (Basic) | -$0.83 | — | -25.8% |
| EPS (Diluted) | -$0.83 | — | -25.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $39.1M | -73.8% | -23.8% |
| Accounts Receivable | $9.3M | +6.2% | -80.8% |
| Inventory | $843K | +104.1% | — |
| Current Assets | $623.8M | -12.0% | -13.9% |
| Total Assets | $652.6M | -11.6% | -12.3% |
| Current Liabilities | $101.5M | -13.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$85.9M | — | -19.4% |
| Capital Expenditures | $128K | — | -56.2% |
| Investing Cash Flow | -$24.2M | — | +76.1% |
| Financing Cash Flow | $69K | — | -51.7% |
| Free Cash Flow | -$86.0M | — | -19.1% |
| +13.1% |
| Long-term Debt | $9.7M | +0.5% | +27.4% |
| Total Liabilities | $544.7M | -3.5% | +43.6% |
| Stockholders' Equity | $107.9M | -38.0% | -70.4% |